- PReS •
- 17 September, 2026 •
- •
Updated Population Pharmacokinetic/Pharmacodynamic Analysis of Emapalumab in Patients With Macrophage Activation Syndrome (MAS) Associated With Still’s Disease and Systemic Lupus Erythematosus (SLE)
Patrick Brossard, Axel Facius, Brian Jamieson
Available materials